Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 6.13150982 |
2 | chaperone-mediated protein transport (GO:0072321) | 5.39546273 |
3 | DNA deamination (GO:0045006) | 5.34428417 |
4 | viral transcription (GO:0019083) | 4.93632514 |
5 | translational termination (GO:0006415) | 4.71395456 |
6 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.61316854 |
7 | ribosomal small subunit biogenesis (GO:0042274) | 4.60017138 |
8 | base-excision repair, AP site formation (GO:0006285) | 4.48037352 |
9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.41780477 |
10 | cotranslational protein targeting to membrane (GO:0006613) | 4.31775532 |
11 | protein targeting to ER (GO:0045047) | 4.29094630 |
12 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.28357303 |
13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.14078526 |
14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.08100914 |
15 | translational elongation (GO:0006414) | 4.05890967 |
16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.03777665 |
17 | maturation of SSU-rRNA (GO:0030490) | 4.02536019 |
18 | protein complex biogenesis (GO:0070271) | 3.98439860 |
19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.96488553 |
20 | ATP synthesis coupled proton transport (GO:0015986) | 3.86341011 |
21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.86341011 |
22 | centriole replication (GO:0007099) | 3.84795265 |
23 | viral life cycle (GO:0019058) | 3.80884536 |
24 | proteasome assembly (GO:0043248) | 3.78995449 |
25 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.73940904 |
26 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.73940904 |
27 | NADH dehydrogenase complex assembly (GO:0010257) | 3.73940904 |
28 | respiratory electron transport chain (GO:0022904) | 3.73360701 |
29 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.69158592 |
30 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.69129693 |
31 | electron transport chain (GO:0022900) | 3.66660595 |
32 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.62612669 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61432838 |
34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.59681447 |
35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.57483992 |
36 | cellular protein complex disassembly (GO:0043624) | 3.57445056 |
37 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.57188143 |
38 | N-acetylneuraminate metabolic process (GO:0006054) | 3.56035905 |
39 | deoxyribose phosphate catabolic process (GO:0046386) | 3.54673156 |
40 | translational initiation (GO:0006413) | 3.52949967 |
41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.48869098 |
42 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.44866312 |
43 | ribosomal large subunit biogenesis (GO:0042273) | 3.42781656 |
44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41645919 |
45 | telomere maintenance via recombination (GO:0000722) | 3.40341284 |
46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.35963092 |
47 | protein deneddylation (GO:0000338) | 3.34779004 |
48 | response to interferon-beta (GO:0035456) | 3.33325180 |
49 | protein targeting to mitochondrion (GO:0006626) | 3.26069958 |
50 | translation (GO:0006412) | 3.25378518 |
51 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.24878225 |
52 | DNA strand elongation (GO:0022616) | 3.21000201 |
53 | sequestering of actin monomers (GO:0042989) | 3.18278899 |
54 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.17769145 |
55 | heme biosynthetic process (GO:0006783) | 3.16537831 |
56 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.15249462 |
57 | regulation of mitochondrial translation (GO:0070129) | 3.13128821 |
58 | protein complex disassembly (GO:0043241) | 3.12276630 |
59 | establishment of protein localization to mitochondrion (GO:0072655) | 3.08542517 |
60 | amino sugar catabolic process (GO:0046348) | 3.06991273 |
61 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.05137604 |
62 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.04965052 |
63 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.04055876 |
64 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.04055876 |
65 | mannosylation (GO:0097502) | 3.03856763 |
66 | peptidyl-histidine modification (GO:0018202) | 3.02175169 |
67 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.01888137 |
68 | positive regulation of prostaglandin secretion (GO:0032308) | 2.97417004 |
69 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97399444 |
70 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.96801220 |
71 | cytidine deamination (GO:0009972) | 2.95999004 |
72 | cytidine metabolic process (GO:0046087) | 2.95999004 |
73 | cytidine catabolic process (GO:0006216) | 2.95999004 |
74 | macromolecular complex disassembly (GO:0032984) | 2.95408005 |
75 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94167002 |
76 | isotype switching (GO:0045190) | 2.93684538 |
77 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.93684538 |
78 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.93684538 |
79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93600552 |
80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93600552 |
81 | mitotic recombination (GO:0006312) | 2.92672799 |
82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92426389 |
83 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.91710479 |
84 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.91710479 |
85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91074720 |
86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91074720 |
87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91074720 |
88 | protein localization to mitochondrion (GO:0070585) | 2.90987908 |
89 | deoxyribose phosphate metabolic process (GO:0019692) | 2.89133759 |
90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87899931 |
91 | respiratory chain complex IV assembly (GO:0008535) | 2.87874285 |
92 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.87334521 |
93 | negative regulation of ligase activity (GO:0051352) | 2.87334521 |
94 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.87212380 |
95 | negative regulation of telomere maintenance (GO:0032205) | 2.86987983 |
96 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.84997243 |
97 | negative regulation of B cell apoptotic process (GO:0002903) | 2.84536100 |
98 | termination of RNA polymerase III transcription (GO:0006386) | 2.84385623 |
99 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84385623 |
100 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.83893349 |
101 | neutrophil activation involved in immune response (GO:0002283) | 2.83503164 |
102 | protein-cofactor linkage (GO:0018065) | 2.83308164 |
103 | rRNA methylation (GO:0031167) | 2.82231768 |
104 | immunoglobulin mediated immune response (GO:0016064) | 2.81206791 |
105 | formation of translation preinitiation complex (GO:0001731) | 2.80090727 |
106 | heme metabolic process (GO:0042168) | 2.78708835 |
107 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.78060874 |
108 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.78060874 |
109 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.77141164 |
110 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76278514 |
111 | mRNA catabolic process (GO:0006402) | 2.75539296 |
112 | cellular response to interferon-beta (GO:0035458) | 2.73869018 |
113 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.73771714 |
114 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.73758935 |
115 | protein targeting to membrane (GO:0006612) | 2.73639101 |
116 | centriole assembly (GO:0098534) | 2.73507674 |
117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73012116 |
118 | B cell mediated immunity (GO:0019724) | 2.72166499 |
119 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.72056029 |
120 | 7-methylguanosine mRNA capping (GO:0006370) | 2.71816893 |
121 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.71572752 |
122 | RNA capping (GO:0036260) | 2.69474110 |
123 | 7-methylguanosine RNA capping (GO:0009452) | 2.69474110 |
124 | telomere maintenance via telomere lengthening (GO:0010833) | 2.68177685 |
125 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.67725162 |
126 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.67542290 |
127 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.65639269 |
128 | hydrogen ion transmembrane transport (GO:1902600) | 2.64678113 |
129 | tRNA processing (GO:0008033) | 2.63528834 |
130 | rRNA processing (GO:0006364) | 2.62874104 |
131 | positive regulation of ligase activity (GO:0051351) | 2.62867433 |
132 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.62563395 |
133 | defense response to protozoan (GO:0042832) | 2.62545079 |
134 | protein neddylation (GO:0045116) | 2.62270369 |
135 | deoxyribonucleotide metabolic process (GO:0009262) | 2.61903753 |
136 | RNA catabolic process (GO:0006401) | 2.61851158 |
137 | platelet dense granule organization (GO:0060155) | 2.61438258 |
138 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.61321868 |
139 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.59716280 |
140 | cellular component biogenesis (GO:0044085) | 2.59676403 |
141 | pseudouridine synthesis (GO:0001522) | 2.59360680 |
142 | cytochrome complex assembly (GO:0017004) | 2.58867798 |
143 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.55484927 |
144 | transcription from mitochondrial promoter (GO:0006390) | 2.55286169 |
145 | establishment of viral latency (GO:0019043) | 2.54213278 |
146 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.54167449 |
147 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.54167449 |
148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53775453 |
149 | rRNA metabolic process (GO:0016072) | 2.52182179 |
150 | signal peptide processing (GO:0006465) | 2.48228054 |
151 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.47526148 |
152 | rRNA modification (GO:0000154) | 2.45888735 |
153 | iron-sulfur cluster assembly (GO:0016226) | 2.44104283 |
154 | metallo-sulfur cluster assembly (GO:0031163) | 2.44104283 |
155 | DNA replication initiation (GO:0006270) | 2.43510664 |
156 | response to protozoan (GO:0001562) | 2.43390462 |
157 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.41448231 |
158 | deoxyribonucleotide catabolic process (GO:0009264) | 2.40819144 |
159 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.40511813 |
160 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40495681 |
161 | mast cell activation (GO:0045576) | 2.40154323 |
162 | spliceosomal snRNP assembly (GO:0000387) | 2.38500322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.69754601 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32601828 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.31086538 |
4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.29210301 |
5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.26823493 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.22692879 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.17339767 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11477330 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99466234 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.86783450 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.74759188 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.72504869 |
13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.64419934 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62088760 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46575637 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42975890 |
17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.40977712 |
18 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37443622 |
19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.34737108 |
20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33895779 |
21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.28229702 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25465754 |
23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.24327817 |
24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.21877000 |
25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19632515 |
26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.11700877 |
27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.09912278 |
28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.07606468 |
29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06243217 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04003599 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01170420 |
32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95964656 |
33 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.93825132 |
34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93096479 |
35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87036113 |
36 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86154417 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85321001 |
38 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81311778 |
39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78991502 |
40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76297251 |
41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75591239 |
42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75568219 |
43 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.73563987 |
44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72552432 |
45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.70500270 |
46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69323071 |
47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68944726 |
48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67233643 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66049817 |
50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.61943365 |
51 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.59439255 |
52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59206546 |
53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57850271 |
54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57227962 |
55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.57207137 |
56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.55178324 |
57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.49708887 |
58 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.47261939 |
59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45578772 |
60 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44584448 |
61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42856719 |
62 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41474444 |
63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41155009 |
64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41132263 |
65 | MYB_26560356_Chip-Seq_TH2_Human | 1.33464423 |
66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32997047 |
67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32603521 |
68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26866682 |
69 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.26337348 |
70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24539544 |
71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23089187 |
72 | MYC_22102868_ChIP-Seq_BL_Human | 1.22826695 |
73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22008788 |
74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20946717 |
75 | MAF_26560356_Chip-Seq_TH1_Human | 1.20499077 |
76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20379172 |
77 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19857886 |
78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19536019 |
79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18970322 |
80 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18859757 |
81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18676211 |
82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18353033 |
83 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17919333 |
84 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17438302 |
85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.17378860 |
86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16993741 |
87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16235114 |
88 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16232302 |
89 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14851980 |
90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14210294 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13587688 |
92 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13443476 |
93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13438675 |
94 | MYB_26560356_Chip-Seq_TH1_Human | 1.13362096 |
95 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12920350 |
96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12275479 |
97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11474748 |
98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11415911 |
99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08536195 |
100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08310110 |
101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08292931 |
102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08171381 |
103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04909015 |
104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04223680 |
105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03971608 |
106 | MAF_26560356_Chip-Seq_TH2_Human | 1.03585833 |
107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03333909 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01337680 |
109 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01272399 |
110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00897303 |
111 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00767181 |
112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00656960 |
113 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00099612 |
114 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99627239 |
115 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98837158 |
116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98061799 |
117 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96684510 |
118 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95934025 |
119 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95918740 |
120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94946938 |
121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94527078 |
122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94007423 |
123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93707779 |
124 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91612136 |
125 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90861853 |
126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90682530 |
127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90581698 |
128 | * P300_27268052_Chip-Seq_Bcells_Human | 0.87272512 |
129 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86349893 |
130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85098157 |
131 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84441801 |
132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84281112 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005083_abnormal_biliary_tract | 4.17495885 |
2 | MP0001835_abnormal_antigen_presentation | 4.13684411 |
3 | MP0003693_abnormal_embryo_hatching | 3.25887906 |
4 | MP0009785_altered_susceptibility_to | 3.21753472 |
5 | MP0005671_abnormal_response_to | 3.04904297 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.95677332 |
7 | MP0000685_abnormal_immune_system | 2.74108458 |
8 | MP0005025_abnormal_response_to | 2.58481876 |
9 | MP0003763_abnormal_thymus_physiology | 2.56331993 |
10 | MP0003436_decreased_susceptibility_to | 2.55888478 |
11 | MP0005000_abnormal_immune_tolerance | 2.54381879 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.50550010 |
13 | MP0009333_abnormal_splenocyte_physiolog | 2.47758289 |
14 | MP0002452_abnormal_antigen_presenting | 2.35523891 |
15 | MP0001800_abnormal_humoral_immune | 2.34422907 |
16 | MP0002396_abnormal_hematopoietic_system | 2.29542954 |
17 | MP0002723_abnormal_immune_serum | 2.28589470 |
18 | MP0001819_abnormal_immune_cell | 2.28265400 |
19 | MP0002420_abnormal_adaptive_immunity | 2.28061882 |
20 | MP0005387_immune_system_phenotype | 2.19660172 |
21 | MP0001790_abnormal_immune_system | 2.19660172 |
22 | MP0002419_abnormal_innate_immunity | 2.17795377 |
23 | MP0004957_abnormal_blastocyst_morpholog | 2.14374490 |
24 | MP0001853_heart_inflammation | 2.13828195 |
25 | MP0002398_abnormal_bone_marrow | 2.10170044 |
26 | MP0008995_early_reproductive_senescence | 2.06799233 |
27 | MP0003724_increased_susceptibility_to | 2.02867142 |
28 | MP0008058_abnormal_DNA_repair | 1.92110724 |
29 | MP0003077_abnormal_cell_cycle | 1.91431500 |
30 | MP0000716_abnormal_immune_system | 1.90694813 |
31 | MP0002132_abnormal_respiratory_system | 1.87328375 |
32 | MP0005365_abnormal_bile_salt | 1.85320002 |
33 | MP0000689_abnormal_spleen_morphology | 1.80261652 |
34 | MP0000490_abnormal_crypts_of | 1.79270303 |
35 | MP0005464_abnormal_platelet_physiology | 1.78351556 |
36 | MP0002405_respiratory_system_inflammati | 1.76909808 |
37 | MP0002722_abnormal_immune_system | 1.75965514 |
38 | MP0010094_abnormal_chromosome_stability | 1.75314516 |
39 | MP0002429_abnormal_blood_cell | 1.73112306 |
40 | MP0005174_abnormal_tail_pigmentation | 1.70714633 |
41 | MP0006035_abnormal_mitochondrial_morpho | 1.70234029 |
42 | MP0010155_abnormal_intestine_physiology | 1.66997487 |
43 | MP0003186_abnormal_redox_activity | 1.66780374 |
44 | MP0008872_abnormal_physiological_respon | 1.62608922 |
45 | MP0005670_abnormal_white_adipose | 1.62501964 |
46 | MP0001529_abnormal_vocalization | 1.61169159 |
47 | MP0009379_abnormal_foot_pigmentation | 1.61107464 |
48 | MP0002166_altered_tumor_susceptibility | 1.59788365 |
49 | MP0008007_abnormal_cellular_replicative | 1.59668008 |
50 | MP0003111_abnormal_nucleus_morphology | 1.59598305 |
51 | MP0000858_altered_metastatic_potential | 1.55227833 |
52 | MP0006292_abnormal_olfactory_placode | 1.53420710 |
53 | MP0003195_calcinosis | 1.53008012 |
54 | MP0003787_abnormal_imprinting | 1.52587338 |
55 | MP0002006_tumorigenesis | 1.52393346 |
56 | MP0001845_abnormal_inflammatory_respons | 1.51048185 |
57 | MP0006082_CNS_inflammation | 1.50702784 |
58 | MP0005645_abnormal_hypothalamus_physiol | 1.49559991 |
59 | MP0008961_abnormal_basal_metabolism | 1.49253967 |
60 | MP0005075_abnormal_melanosome_morpholog | 1.48060075 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.46351603 |
62 | MP0001545_abnormal_hematopoietic_system | 1.46351603 |
63 | MP0004808_abnormal_hematopoietic_stem | 1.45975957 |
64 | MP0005310_abnormal_salivary_gland | 1.45433610 |
65 | MP0001905_abnormal_dopamine_level | 1.43883238 |
66 | MP0003252_abnormal_bile_duct | 1.43357571 |
67 | MP0003866_abnormal_defecation | 1.42240200 |
68 | MP0001873_stomach_inflammation | 1.41477712 |
69 | MP0004043_abnormal_pH_regulation | 1.40858317 |
70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40710553 |
71 | MP0008057_abnormal_DNA_replication | 1.37299624 |
72 | MP0002163_abnormal_gland_morphology | 1.34891661 |
73 | MP0002019_abnormal_tumor_incidence | 1.33403994 |
74 | MP0000703_abnormal_thymus_morphology | 1.32789779 |
75 | MP0002254_reproductive_system_inflammat | 1.26429950 |
76 | MP0003786_premature_aging | 1.26108335 |
77 | MP0008469_abnormal_protein_level | 1.24114137 |
78 | MP0006072_abnormal_retinal_apoptosis | 1.23524318 |
79 | MP0005085_abnormal_gallbladder_physiolo | 1.22775450 |
80 | MP0008789_abnormal_olfactory_epithelium | 1.21691731 |
81 | MP0004510_myositis | 1.20958619 |
82 | MP0000343_altered_response_to | 1.18595273 |
83 | MP0000313_abnormal_cell_death | 1.13918387 |
84 | MP0000465_gastrointestinal_hemorrhage | 1.13117189 |
85 | MP0002837_dystrophic_cardiac_calcinosis | 1.12363414 |
86 | MP0002653_abnormal_ependyma_morphology | 1.09566485 |
87 | MP0004147_increased_porphyrin_level | 1.08131021 |
88 | MP0003123_paternal_imprinting | 1.05102239 |
89 | MP0002095_abnormal_skin_pigmentation | 1.04313583 |
90 | MP0005410_abnormal_fertilization | 1.04005902 |
91 | MP0005646_abnormal_pituitary_gland | 1.03448146 |
92 | MP0001533_abnormal_skeleton_physiology | 1.02178681 |
93 | MP0006036_abnormal_mitochondrial_physio | 1.01843377 |
94 | MP0002876_abnormal_thyroid_physiology | 0.99574663 |
95 | MP0002736_abnormal_nociception_after | 0.98906393 |
96 | MP0003448_altered_tumor_morphology | 0.98383107 |
97 | MP0000015_abnormal_ear_pigmentation | 0.98319202 |
98 | MP0005551_abnormal_eye_electrophysiolog | 0.97587701 |
99 | MP0002138_abnormal_hepatobiliary_system | 0.97559290 |
100 | MP0002693_abnormal_pancreas_physiology | 0.96722304 |
101 | MP0004947_skin_inflammation | 0.95890235 |
102 | MP0004142_abnormal_muscle_tone | 0.95531531 |
103 | MP0008932_abnormal_embryonic_tissue | 0.94193599 |
104 | MP0005636_abnormal_mineral_homeostasis | 0.93653167 |
105 | MP0005367_renal/urinary_system_phenotyp | 0.93445345 |
106 | MP0000516_abnormal_urinary_system | 0.93445345 |
107 | MP0001929_abnormal_gametogenesis | 0.93370122 |
108 | MP0005253_abnormal_eye_physiology | 0.93262877 |
109 | MP0001986_abnormal_taste_sensitivity | 0.91848416 |
110 | MP0002933_joint_inflammation | 0.88602966 |
111 | MP0010329_abnormal_lipoprotein_level | 0.88384710 |
112 | MP0002210_abnormal_sex_determination | 0.88044781 |
113 | MP0000372_irregular_coat_pigmentation | 0.87571884 |
114 | MP0004782_abnormal_surfactant_physiolog | 0.87492188 |
115 | MP0002277_abnormal_respiratory_mucosa | 0.84378504 |
116 | MP0000358_abnormal_cell_content/ | 0.83280637 |
117 | MP0009643_abnormal_urine_homeostasis | 0.82584526 |
118 | MP0001919_abnormal_reproductive_system | 0.81877370 |
119 | MP0005266_abnormal_metabolism | 0.81539908 |
120 | MP0003011_delayed_dark_adaptation | 0.80530223 |
121 | MP0006054_spinal_hemorrhage | 0.80022841 |
122 | MP0005377_hearing/vestibular/ear_phenot | 0.79972572 |
123 | MP0003828_pulmonary_edema | 0.77728721 |
124 | MP0004381_abnormal_hair_follicle | 0.75975056 |
125 | MP0005379_endocrine/exocrine_gland_phen | 0.73524386 |
126 | MP0008877_abnormal_DNA_methylation | 0.73397180 |
127 | MP0009764_decreased_sensitivity_to | 0.72787809 |
128 | MP0005084_abnormal_gallbladder_morpholo | 0.70311442 |
129 | MP0001348_abnormal_lacrimal_gland | 0.69978651 |
130 | MP0000350_abnormal_cell_proliferation | 0.69216851 |
131 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66060848 |
132 | MP0008260_abnormal_autophagy | 0.65954063 |
133 | MP0001663_abnormal_digestive_system | 0.65947144 |
134 | MP0003183_abnormal_peptide_metabolism | 0.62221883 |
135 | MP0003656_abnormal_erythrocyte_physiolo | 0.62190859 |
136 | MP0003943_abnormal_hepatobiliary_system | 0.60445357 |
137 | MP0009763_increased_sensitivity_to | 0.59665851 |
138 | MP0003718_maternal_effect | 0.57748773 |
139 | MP0009697_abnormal_copulation | 0.56392424 |
140 | MP0002638_abnormal_pupillary_reflex | 0.56168392 |
141 | MP0005451_abnormal_body_composition | 0.55995139 |
142 | MP0001764_abnormal_homeostasis | 0.55827794 |
143 | MP0005058_abnormal_lysosome_morphology | 0.55823894 |
144 | MP0001851_eye_inflammation | 0.55388026 |
145 | MP0001346_abnormal_lacrimal_gland | 0.53665096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.68337982 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 4.55212911 |
3 | Recurrent abscess formation (HP:0002722) | 4.41152752 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.30555103 |
5 | Reticulocytopenia (HP:0001896) | 4.22306065 |
6 | IgM deficiency (HP:0002850) | 3.80513870 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.79025881 |
8 | Progressive macrocephaly (HP:0004481) | 3.78964808 |
9 | Increased muscle lipid content (HP:0009058) | 3.54024388 |
10 | Thrombocytosis (HP:0001894) | 3.51379798 |
11 | Myositis (HP:0100614) | 3.44519218 |
12 | Petechiae (HP:0000967) | 3.42859794 |
13 | Cerebral edema (HP:0002181) | 3.35476611 |
14 | Eczematoid dermatitis (HP:0000976) | 3.34471455 |
15 | Aplastic anemia (HP:0001915) | 3.18258595 |
16 | Lactic acidosis (HP:0003128) | 3.17396743 |
17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.08046704 |
18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.08046704 |
19 | Pallor (HP:0000980) | 3.01044183 |
20 | Type I transferrin isoform profile (HP:0003642) | 3.00440306 |
21 | Hepatocellular necrosis (HP:0001404) | 2.97602007 |
22 | Abnormality of macrophages (HP:0004311) | 2.92967498 |
23 | Exertional dyspnea (HP:0002875) | 2.91588657 |
24 | 3-Methylglutaconic aciduria (HP:0003535) | 2.90599974 |
25 | Macrocytic anemia (HP:0001972) | 2.87073790 |
26 | Microvesicular hepatic steatosis (HP:0001414) | 2.86300151 |
27 | Mitochondrial inheritance (HP:0001427) | 2.83044844 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 2.82775601 |
29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.80505174 |
30 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.75863568 |
31 | Progressive microcephaly (HP:0000253) | 2.74335054 |
32 | Hepatic necrosis (HP:0002605) | 2.74021333 |
33 | Chronic otitis media (HP:0000389) | 2.67168600 |
34 | Obstructive lung disease (HP:0006536) | 2.66714249 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66714249 |
36 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64213110 |
37 | Recurrent bronchitis (HP:0002837) | 2.64041102 |
38 | Muscle fiber atrophy (HP:0100295) | 2.61893872 |
39 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61257759 |
40 | IgG deficiency (HP:0004315) | 2.58541042 |
41 | Acute necrotizing encephalopathy (HP:0006965) | 2.56459114 |
42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.53759171 |
43 | Respiratory failure (HP:0002878) | 2.48295211 |
44 | Stomatitis (HP:0010280) | 2.47501236 |
45 | Abnormality of the prostate (HP:0008775) | 2.46179468 |
46 | Abnormality of T cell physiology (HP:0011840) | 2.44629861 |
47 | Recurrent fungal infections (HP:0002841) | 2.43877494 |
48 | Optic disc pallor (HP:0000543) | 2.41702331 |
49 | Meningitis (HP:0001287) | 2.38939585 |
50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38928210 |
51 | Increased IgM level (HP:0003496) | 2.38138482 |
52 | Increased CSF lactate (HP:0002490) | 2.38061431 |
53 | Recurrent skin infections (HP:0001581) | 2.37848031 |
54 | Pustule (HP:0200039) | 2.34304694 |
55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33355522 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.33355522 |
57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32782988 |
58 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32782988 |
59 | Abnormal protein glycosylation (HP:0012346) | 2.32782988 |
60 | Abnormal glycosylation (HP:0012345) | 2.32782988 |
61 | Poor head control (HP:0002421) | 2.32279734 |
62 | 11 pairs of ribs (HP:0000878) | 2.31452453 |
63 | Orchitis (HP:0100796) | 2.31196369 |
64 | Retrobulbar optic neuritis (HP:0100654) | 2.30912378 |
65 | Optic neuritis (HP:0100653) | 2.30912378 |
66 | Methylmalonic aciduria (HP:0012120) | 2.28346817 |
67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27765807 |
68 | Reduced antithrombin III activity (HP:0001976) | 2.27184789 |
69 | Vasculitis (HP:0002633) | 2.24801755 |
70 | Abnormality of T cells (HP:0002843) | 2.24131707 |
71 | Renal Fanconi syndrome (HP:0001994) | 2.23344564 |
72 | Combined immunodeficiency (HP:0005387) | 2.22850346 |
73 | Lymphoma (HP:0002665) | 2.22685891 |
74 | Increased serum lactate (HP:0002151) | 2.22446221 |
75 | Vacuolated lymphocytes (HP:0001922) | 2.20201528 |
76 | Recurrent viral infections (HP:0004429) | 2.18864710 |
77 | Methylmalonic acidemia (HP:0002912) | 2.16180942 |
78 | Respiratory difficulties (HP:0002880) | 2.14411814 |
79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11655603 |
80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11042412 |
81 | Lymphopenia (HP:0001888) | 2.09941260 |
82 | Prolonged bleeding time (HP:0003010) | 2.09584320 |
83 | Lethargy (HP:0001254) | 2.09270337 |
84 | CNS demyelination (HP:0007305) | 2.08840329 |
85 | Agnosia (HP:0010524) | 2.08533206 |
86 | Abnormality of alanine metabolism (HP:0010916) | 2.08265209 |
87 | Hyperalaninemia (HP:0003348) | 2.08265209 |
88 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08265209 |
89 | Emotional lability (HP:0000712) | 2.05825951 |
90 | Abnormality of renal resorption (HP:0011038) | 2.05787988 |
91 | Abnormality of urine glucose concentration (HP:0011016) | 2.05775877 |
92 | Glycosuria (HP:0003076) | 2.05775877 |
93 | Birth length less than 3rd percentile (HP:0003561) | 2.04961962 |
94 | Nasal polyposis (HP:0100582) | 2.04433340 |
95 | Granulocytopenia (HP:0001913) | 2.04266535 |
96 | Pancytopenia (HP:0001876) | 2.02488041 |
97 | Basal ganglia calcification (HP:0002135) | 2.00987242 |
98 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00573846 |
99 | Generalized aminoaciduria (HP:0002909) | 2.00418395 |
100 | Ketosis (HP:0001946) | 1.99753202 |
101 | Recurrent pneumonia (HP:0006532) | 1.97951271 |
102 | Chromsome breakage (HP:0040012) | 1.97277391 |
103 | Hyperglycinemia (HP:0002154) | 1.95387130 |
104 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94785066 |
105 | Pancreatic cysts (HP:0001737) | 1.94391916 |
106 | Oral leukoplakia (HP:0002745) | 1.92551925 |
107 | Leukocytosis (HP:0001974) | 1.92439787 |
108 | Abnormality of the renal cortex (HP:0011035) | 1.92342125 |
109 | Abnormality of B cell number (HP:0010975) | 1.92120838 |
110 | B lymphocytopenia (HP:0010976) | 1.92120838 |
111 | Increased serum pyruvate (HP:0003542) | 1.91194970 |
112 | Microretrognathia (HP:0000308) | 1.90317628 |
113 | Medial flaring of the eyebrow (HP:0010747) | 1.90240703 |
114 | Hypergammaglobulinemia (HP:0010702) | 1.90130990 |
115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.88392862 |
116 | Exercise intolerance (HP:0003546) | 1.88000410 |
117 | Abnormality of the nasal mucosa (HP:0000433) | 1.87938414 |
118 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87721012 |
119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87550442 |
120 | Myelodysplasia (HP:0002863) | 1.87103571 |
121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86853721 |
122 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86853721 |
123 | Neutropenia (HP:0001875) | 1.85562678 |
124 | Acute encephalopathy (HP:0006846) | 1.83990165 |
125 | Gingivitis (HP:0000230) | 1.83562215 |
126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.83329919 |
127 | Severe combined immunodeficiency (HP:0004430) | 1.83317337 |
128 | Poikiloderma (HP:0001029) | 1.82976978 |
129 | Bone marrow hypocellularity (HP:0005528) | 1.82178244 |
130 | Hepatosplenomegaly (HP:0001433) | 1.81648043 |
131 | Ketoacidosis (HP:0001993) | 1.81277745 |
132 | Panhypogammaglobulinemia (HP:0003139) | 1.81199308 |
133 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80373001 |
134 | Abnormality of eosinophils (HP:0001879) | 1.80238139 |
135 | Leukodystrophy (HP:0002415) | 1.80217068 |
136 | Prostate neoplasm (HP:0100787) | 1.77488168 |
137 | Congenital stationary night blindness (HP:0007642) | 1.73666359 |
138 | Absent thumb (HP:0009777) | 1.73538881 |
139 | Cleft eyelid (HP:0000625) | 1.73488079 |
140 | Ragged-red muscle fibers (HP:0003200) | 1.72347433 |
141 | Cutaneous photosensitivity (HP:0000992) | 1.71258775 |
142 | Prominent metopic ridge (HP:0005487) | 1.70266141 |
143 | Meckel diverticulum (HP:0002245) | 1.69898467 |
144 | Hypomagnesemia (HP:0002917) | 1.65877692 |
145 | Cerebral hypomyelination (HP:0006808) | 1.64822434 |
146 | Hyperphosphaturia (HP:0003109) | 1.64205239 |
147 | Abnormality of the ileum (HP:0001549) | 1.63948732 |
148 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.63745352 |
149 | Severe visual impairment (HP:0001141) | 1.60409445 |
150 | Abnormality of glycolysis (HP:0004366) | 1.59659309 |
151 | Abnormality of the preputium (HP:0100587) | 1.59155995 |
152 | Thyroiditis (HP:0100646) | 1.58893840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.04742925 |
2 | CCNB1 | 3.87718234 |
3 | NME2 | 3.79648975 |
4 | BUB1 | 3.36524432 |
5 | BCKDK | 3.33879602 |
6 | STK16 | 2.95091202 |
7 | MAP4K1 | 2.94080299 |
8 | IRAK4 | 2.55615532 |
9 | NUAK1 | 2.53274919 |
10 | BLK | 2.37786043 |
11 | PIM2 | 2.31835955 |
12 | WEE1 | 2.17654779 |
13 | IRAK3 | 2.09610108 |
14 | CAMKK2 | 2.02350120 |
15 | TXK | 1.95058645 |
16 | KDR | 1.88446073 |
17 | EIF2AK1 | 1.88169900 |
18 | RPS6KA4 | 1.87468746 |
19 | TEC | 1.85146842 |
20 | TYK2 | 1.82601501 |
21 | BTK | 1.79421622 |
22 | SRPK1 | 1.72527273 |
23 | MAP4K2 | 1.69418686 |
24 | KIT | 1.69344621 |
25 | TBK1 | 1.69240566 |
26 | TAOK3 | 1.68332964 |
27 | VRK1 | 1.67973837 |
28 | MUSK | 1.67815957 |
29 | ACVR1B | 1.66580314 |
30 | TLK1 | 1.53235495 |
31 | ZAP70 | 1.51137833 |
32 | WNK4 | 1.49470776 |
33 | MAP3K12 | 1.46880308 |
34 | IKBKE | 1.45636406 |
35 | DYRK3 | 1.44340213 |
36 | JAK3 | 1.43926743 |
37 | EIF2AK3 | 1.43612753 |
38 | IKBKB | 1.42406633 |
39 | LIMK1 | 1.41411377 |
40 | PDK2 | 1.30810308 |
41 | TESK2 | 1.30236919 |
42 | PLK4 | 1.29944739 |
43 | SYK | 1.21448081 |
44 | DAPK1 | 1.20366031 |
45 | MST4 | 1.17686140 |
46 | MAP3K14 | 1.17300323 |
47 | CLK1 | 1.17217271 |
48 | MYLK | 1.17195336 |
49 | TAF1 | 1.16898983 |
50 | BRSK2 | 1.15802180 |
51 | DYRK2 | 1.15447404 |
52 | ADRBK2 | 1.12175575 |
53 | TRIM28 | 1.03399675 |
54 | CSNK1G3 | 1.03053408 |
55 | CDK19 | 1.02686693 |
56 | PIM1 | 1.02219571 |
57 | ARAF | 1.02141606 |
58 | MAP3K11 | 1.00518927 |
59 | CSF1R | 1.00517197 |
60 | LYN | 0.98243626 |
61 | RIPK4 | 0.94258137 |
62 | ZAK | 0.92795749 |
63 | CAMK1D | 0.87126169 |
64 | NEK1 | 0.86883477 |
65 | STK4 | 0.86022590 |
66 | TGFBR1 | 0.84461379 |
67 | MAP2K3 | 0.83971186 |
68 | RPS6KA5 | 0.83845705 |
69 | FES | 0.82717268 |
70 | NLK | 0.81972271 |
71 | ILK | 0.81866754 |
72 | PASK | 0.81779397 |
73 | CDK7 | 0.81447638 |
74 | AURKB | 0.80576783 |
75 | PAK4 | 0.80495014 |
76 | FLT3 | 0.79468955 |
77 | RPS6KB2 | 0.79089350 |
78 | FRK | 0.78496454 |
79 | LCK | 0.76877522 |
80 | EIF2AK2 | 0.74825560 |
81 | BRAF | 0.74713436 |
82 | CSNK1G2 | 0.73716145 |
83 | MAP2K6 | 0.73220135 |
84 | TESK1 | 0.73156247 |
85 | MKNK1 | 0.72989665 |
86 | STK10 | 0.72650311 |
87 | NEK2 | 0.72034016 |
88 | YES1 | 0.71636037 |
89 | CSNK1G1 | 0.71234954 |
90 | SIK3 | 0.70706890 |
91 | ABL2 | 0.70315761 |
92 | LRRK2 | 0.69919387 |
93 | PRKCQ | 0.69596933 |
94 | PBK | 0.69518210 |
95 | AURKA | 0.69417213 |
96 | WNK3 | 0.65769013 |
97 | MAP2K7 | 0.65411066 |
98 | TIE1 | 0.65281964 |
99 | BMPR1B | 0.65039935 |
100 | OXSR1 | 0.64155184 |
101 | PINK1 | 0.64003213 |
102 | TNK2 | 0.63908202 |
103 | CDC7 | 0.63348870 |
104 | MAPKAPK3 | 0.63156349 |
105 | GRK6 | 0.62907037 |
106 | ATR | 0.61870287 |
107 | NME1 | 0.61081756 |
108 | TGFBR2 | 0.60949096 |
109 | MATK | 0.58331216 |
110 | PLK1 | 0.57729009 |
111 | CSNK1A1L | 0.56552210 |
112 | INSRR | 0.55900543 |
113 | PLK3 | 0.55341084 |
114 | CHUK | 0.54706737 |
115 | MAP3K8 | 0.53661680 |
116 | MAPKAPK2 | 0.53660814 |
117 | CSNK2A1 | 0.53428631 |
118 | DAPK3 | 0.52602669 |
119 | TTK | 0.52409350 |
120 | GRK7 | 0.50515054 |
121 | ITK | 0.50125410 |
122 | CSK | 0.49812576 |
123 | RPS6KA6 | 0.49552173 |
124 | PRKG2 | 0.48456730 |
125 | NEK9 | 0.46768252 |
126 | GRK5 | 0.46691687 |
127 | TSSK6 | 0.46221249 |
128 | GRK1 | 0.45941886 |
129 | STK24 | 0.45786970 |
130 | HCK | 0.45318134 |
131 | ERN1 | 0.44727090 |
132 | PRKCI | 0.44149014 |
133 | RPS6KL1 | 0.44036201 |
134 | RPS6KC1 | 0.44036201 |
135 | CSNK2A2 | 0.43456337 |
136 | MAP2K2 | 0.43103296 |
137 | PRKCD | 0.42823393 |
138 | CAMK1 | 0.40660618 |
139 | SCYL2 | 0.40444707 |
140 | MAPK13 | 0.39484608 |
141 | MAPKAPK5 | 0.35916476 |
142 | STK39 | 0.34840176 |
143 | MAP3K4 | 0.30616112 |
144 | CHEK2 | 0.28419851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.63792821 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.69999956 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.61603355 |
4 | RNA polymerase_Homo sapiens_hsa03020 | 3.01674585 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.93141743 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.67841981 |
7 | Homologous recombination_Homo sapiens_hsa03440 | 2.55961507 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.45894997 |
9 | * Spliceosome_Homo sapiens_hsa03040 | 2.38701774 |
10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.21970007 |
11 | Protein export_Homo sapiens_hsa03060 | 2.17535972 |
12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.14888680 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06115403 |
14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86493049 |
15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79316282 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.71997588 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70171528 |
18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69291917 |
19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.60579189 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.47896825 |
21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47090257 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46235873 |
23 | RNA degradation_Homo sapiens_hsa03018 | 1.46133437 |
24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42019420 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40343281 |
26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39462377 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32179020 |
28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31649705 |
29 | Measles_Homo sapiens_hsa05162 | 1.30695332 |
30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28263520 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26574729 |
32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25815914 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24403077 |
34 | RNA transport_Homo sapiens_hsa03013 | 1.22927120 |
35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22816344 |
36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22682583 |
37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22585965 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20727246 |
39 | Purine metabolism_Homo sapiens_hsa00230 | 1.19400491 |
40 | Asthma_Homo sapiens_hsa05310 | 1.18270344 |
41 | Peroxisome_Homo sapiens_hsa04146 | 1.17476449 |
42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.17090773 |
43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16621541 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.15735858 |
45 | Cell cycle_Homo sapiens_hsa04110 | 1.13797113 |
46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12167884 |
47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11345900 |
48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05550156 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04893820 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00750588 |
51 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00719739 |
52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00570159 |
53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98383270 |
54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97913814 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95733415 |
56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95030134 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94429565 |
58 | Phototransduction_Homo sapiens_hsa04744 | 0.90394054 |
59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90013510 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89364336 |
61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87575886 |
62 | Shigellosis_Homo sapiens_hsa05131 | 0.84414624 |
63 | Pertussis_Homo sapiens_hsa05133 | 0.83927286 |
64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83140374 |
65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79379106 |
66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79165532 |
67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78302338 |
68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78198105 |
69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77831552 |
70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77554461 |
71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75715705 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.75503012 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74433577 |
74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71944588 |
75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71643975 |
76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71380261 |
77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70786046 |
78 | Apoptosis_Homo sapiens_hsa04210 | 0.70572791 |
79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70046052 |
80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69894462 |
81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69765993 |
82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67824531 |
83 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65058344 |
84 | Malaria_Homo sapiens_hsa05144 | 0.64146746 |
85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62655100 |
86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60087701 |
87 | Tuberculosis_Homo sapiens_hsa05152 | 0.59886792 |
88 | Salmonella infection_Homo sapiens_hsa05132 | 0.58476102 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57952191 |
90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57676514 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57099600 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56787740 |
93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55878343 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55644449 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53469057 |
96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51488015 |
97 | Hepatitis B_Homo sapiens_hsa05161 | 0.50982685 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48722873 |
99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46422456 |
100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46366087 |
101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45555200 |
102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44718837 |
103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44621164 |
104 | Lysosome_Homo sapiens_hsa04142 | 0.44595504 |
105 | Phagosome_Homo sapiens_hsa04145 | 0.44208240 |
106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43648273 |
107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43416226 |
108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43136190 |
109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43096388 |
110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42997137 |
111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41423751 |
112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40880013 |
113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40379700 |
114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40328655 |
115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40112443 |
116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40075478 |
117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39526523 |
118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39054156 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39011335 |
120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38428523 |
121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36597719 |
122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35180814 |
123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34759766 |
124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34576140 |
125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34258505 |
126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33356661 |
127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33004738 |
128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31398984 |
129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31216596 |
130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31200831 |
131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30968500 |
132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30833873 |
133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30728190 |
134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28960436 |
135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27786071 |
136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27428208 |
137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26863669 |
138 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26664550 |
139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26337261 |
140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26224126 |
141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25583426 |